(Q35704498)

9 August 2017

Efficacy of galactose and adalimumab in patients with resistant focal segmental glomerulosclerosis: report of the font clinical trial group (English)

1 reference

focal segmental glomerulosclerosis

9 August 2017

0 references

1 reference

5

Jennifer Gassman

1 reference

9 August 2017

Debbie S Gipson

13

0 references

Howard Trachtman

object named as

Howard Trachtman

1

0 references

Virginia J Savin

7

object named as

Virginia J Savin

1 reference

9 August 2017

Suzanne Vento

2

1 reference

9 August 2017

Emily Herreshoff

3

1 reference

9 August 2017

Milena Radeva

4

1 reference

9 August 2017

Daniel T Stein

6

1 reference

9 August 2017

Mukut Sharma

8

1 reference

9 August 2017

Jochen Reiser

9

1 reference

9 August 2017

Changli Wei

10

1 reference

9 August 2017

Michael Somers

11

1 reference

9 August 2017

Tarak Srivastava

12

1 reference

9 August 2017

22 July 2015

1 reference

9 August 2017

1 reference

9 August 2017

16

1 reference

9 August 2017

111

1 reference

Creative Commons Attribution 4.0 International

9 August 2017

start time

22 July 2015

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Causes and pathogenesis of focal segmental glomerulosclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Focal segmental glomerulosclerosis recurrence in the renal allograft.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Treatment of FSGS in Children

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Adaptive clinical trial design

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

The landscape of clinical trials in nephrology: a systematic review of Clinicaltrials.gov

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Single-patient (n-of-1) trials: a pragmatic clinical decision methodology for patient-centered comparative effectiveness research

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Effect of galactose on glomerular permeability and proteinuria in steroid-resistant nephrotic syndrome

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Patient recruitment into a multicenter randomized clinical trial for kidney disease: report of the focal segmental glomerulosclerosis clinical trial (FSGS CT).

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Circulating suPAR in two cohorts of primary FSGS.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Clinical trial of focal segmental glomerulosclerosis in children and young adults

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Phase 1 trial of adalimumab in Focal Segmental Glomerulosclerosis (FSGS): II. Report of the FONT (Novel Therapies for Resistant FSGS) study group

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

The number, quality, and coverage of randomized controlled trials in nephrology.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Analysis of concentration and (13)C enrichment of D-galactose in human plasma

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

FSGS permeability factor-associated nephrotic syndrome: remission after oral galactose therapy

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Galactose binds to focal segmental glomerulosclerosis permeability factor and inhibits its activity

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Differential risk of remission and ESRD in childhood FSGS.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4511259

Randomized phase II clinical trials

25 September 2018

1 reference

12 December 2020

Measurement of albumin reflection coefficient with isolated rat glomeruli

1 reference

12 December 2020

New players in the pathogenesis of focal segmental glomerulosclerosis

1 reference

12 December 2020

Risk of mortality, fatal infection, and fatal malignancy related to use of anti-tumor necrosis factor-α biologics by rheumatoid arthritis patients

1 reference

12 December 2020

10.1186/S12882-015-0094-5

Identifiers

DOI

1 reference

9 August 2017

1 reference

9 August 2017

1 reference